News | November 13, 2021
Aster DM Healthcare PAT at Rs 107 cr. in Q2FY22
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
The company is a medical dictation solution used by medical practitioners
Acute therapies continue to report strong growth compared to chronic ones.
The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India
Preliminary data from the first 20 participants in Azerbaijan show antibodies to the SARS-CoV-2 virus spike protein (S-protein) elicited in 100% of cases
The phase 3 clinical trial of Sputnik V will be conducted on 1,500 subjects as part of the randomized, double blind, parallel group placebo controlled study in India.
Subscribe To Our Newsletter & Stay Updated
